GW Pharma's cannabis-derived epilepsy medicine makes the cut in the European Union
GW Pharma’s cannabis-derived medicine for epilepsy has won European endorsement, more than a year after the British drugmaker secured its landmark US approval. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
